Aker BioMarine ASA (DE:1PG) has released an update.
Aker BioMarine ASA is set to sharpen its focus on human nutrition and the Omega-3 market following the sale of its Feed Ingredients business for USD 590 million. The company reported a 6% increase in total revenue to USD 94.0 million and a 35% rise in Adjusted EBITDA to USD 29.0 million year-over-year for Q2 2024, including discontinued operations. Despite this, continued operations alone saw a slight revenue increase of 4% but a 21% decrease in Adjusted EBITDA.
For further insights into DE:1PG stock, check out TipRanks’ Stock Analysis page.
